| Michael I Gruenebaum, MD | |
|
8550 Marshall Dr, Suite 200, Lenexa, KS 66214-1505 | |
| (913) 495-2000 | |
| (913) 495-3715 |
| Full Name | Michael I Gruenebaum |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 8550 Marshall Dr, Lenexa, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215943287 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 04-21307 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael I Gruenebaum, MD 8550 Marshall Dr, Suite 220 Administration, Lenexa, KS 66214-1505 Ph: (913) 495-2000 | Michael I Gruenebaum, MD 8550 Marshall Dr, Suite 200, Lenexa, KS 66214-1505 Ph: (913) 495-2000 |
News Archive
House Democrats are preparing to introduce legislation on Medicare drug prices and an effort to tackle some individual health issues while Congress debates a comprehensive bill.
For many consumers, an unexpected health care calamity can quickly burgeon into a financial calamity. Just over half of all the debt that appears on credit reports is related to medical expenses, and consumers may find that their credit score gets as banged up as their body.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application filed May 27, 2011 for a novel topical Lidocaine Spray formulation (NRI-ANA), allowing for initiation of Phase 1 studies.
Researchers at Karolinska Institutet have shown that they may be able to monitor the aging process in the brain, by using MRI technique to measure the brain lactic acid levels. Their findings suggest that the lactate levels increase in advance of other aging symptoms, and therefore could be used as an indicator of aging and age-related diseases of the CNS.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has accepted for review the complete response submission made by Endo to the new drug application for its long-acting testosterone undecanoate injection, AVEED, intended for men diagnosed with hypogonadism.
› Verified 7 days ago
Lisa Marie Madsen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 23351 Prairie Star Pkwy, Suite A245, Lenexa, KS 66227 Phone: 913-676-8630 Fax: 913-676-8635 | |
Ravi S Singh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8600 Quivira Rd Ste 100, Lenexa, KS 66215 Phone: 913-831-7400 Fax: 913-831-7409 | |
Frederick Carter Newton, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8805 Long St, Lenexa, KS 66215 Phone: 913-888-8866 | |
Dr. Ratnesh Kumar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10950 W 86th St, Lenexa, KS 66214 Phone: 913-722-4240 | |
Dr. Simerun Singh, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 12200 W 106th St Ste 325, Lenexa, KS 66215 Phone: 785-218-5820 | |
Dr. Judy Lucena Panek, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 16300 College Blvd, Lenexa, KS 66219 Phone: 913-410-2906 |